Related references
Note: Only part of the references are listed.Chitosan-based vaccine adjuvants: incomplete characterization complicates preclinical and clinical evaluation
Yuri M. Vasiliev
EXPERT REVIEW OF VACCINES (2015)
Vaccine Potentiation by Combination Adjuvants
Benoit Levast et al.
VACCINES (2014)
In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations
Regina Scherliess et al.
VACCINE (2013)
In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines
Michael J. Heffernan et al.
BIOMATERIALS (2011)
Vaccines with Aluminum-containing Adjuvants: Optimizing Vaccine Efficacy and Thermal Stability
Tanya Clapp et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Chitosan Nanoparticles Act as an Adjuvant to Promote both Th1 and Th2 Immune Responses Induced by Ovalbumin in Mice
Zheng-Shun Wen et al.
MARINE DRUGS (2011)
Biodegradation, biodistribution and toxicity of chitosan
T. Kean et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Biopolymer encapsulated live influenza virus as a universal CD8+T cell vaccine against influenza virus
Alina C. Boesteanu et al.
VACCINE (2010)
Adjuvanticity effect of sodium alginate on subcutaneously injected BCG in BALB/c mice
Faramarz Dobakhti et al.
MICROBES AND INFECTION (2009)
Preparation of alginate coated chitosan microparticles for vaccine delivery
XingYi Li et al.
BMC BIOTECHNOLOGY (2008)
Improving vaccine delivery using novel adjuvant systems
Michael E. Pichichero
HUMAN VACCINES (2008)
Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen
Olga Borges et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2008)
Vaccine adjuvant systems: Enhancing the efficacy of sub-unit protein antigens
Yvonne Perrie et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine
Kristina Cardell et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response
Bethany Hansen et al.
VACCINE (2007)
Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection
Yong Xie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
D Lavanchy
JOURNAL OF VIRAL HEPATITIS (2004)
Aluminium compounds for use in vaccines
EB Lindblad
IMMUNOLOGY AND CELL BIOLOGY (2004)
Inhibition of hepatitis B virus expression and replication by RNA interference
A Shlomai et al.
HEPATOLOGY (2003)
CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice
R Weeratna et al.
IMMUNOLOGY AND CELL BIOLOGY (2003)
Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle
RK Gherardi et al.
BRAIN (2001)
T-cell subsets (Th1 versus Th2)
S Romagnani
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2000)
Share Paper
